{"id":23428,"date":"2026-11-13T16:30:41","date_gmt":"2026-11-13T14:30:41","guid":{"rendered":"https:\/\/farmacija-mic.lv\/?p=23428"},"modified":"2026-11-13T16:40:30","modified_gmt":"2026-11-13T14:40:30","slug":"aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/","title":{"rendered":"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Izteiktu laika tr\u016bkumu vai p\u0101rslodzi darb\u0101 izj\u016bt 39% Latvij\u0101 aptauj\u0101to darbinieku, savuk\u0101rt Eiropas Savien\u012bb\u0101 (ES) par to zi\u0146oju\u0161i 44% aptauj\u0101to, liecina Valsts darba inspekcijas (VDI) piektdienas konferenc\u0113 apl\u016bkot\u0101s Eiropas Darba dro\u0161\u012bbas un vesel\u012bbas aizsardz\u012bbas a\u0123ent\u016bras (EU-OSHA) aptaujas &#8220;OSH Pulse 2025&#8221; dati.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">VDI sadarb\u012bb\u0101 ar EU-OSHA piektdien r\u012bko konferenci &#8220;Redz\u0113t neredzamo: psihosoci\u0101lo risku atpaz\u012b\u0161ana un nov\u0113rt\u0113\u0161ana darba vid\u0113&#8221;. Taj\u0101 sprie\u017e par to, k\u0101 laikus paman\u012bt un nov\u0113rt\u0113t psihosoci\u0101los riskus darbaviet\u0101 un k\u0101dus pas\u0101kumus darba dev\u0113ji var \u012bstenot to mazin\u0101\u0161anai.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Latvij\u0101 32% aptauj\u0101to nor\u0101d\u012bju\u0161i, ka 12 m\u0113ne\u0161os pirms aptaujas piedz\u012bvoju\u0161i stresu, depresiju vai trauksmi, ko izrais\u012bjis vai pastiprin\u0101jis darbs. ES kopum\u0101 \u0161is \u012bpatsvars bija 29%. Par visp\u0101r\u0113ju nogurumu, ko izrais\u012bjis vai pastiprin\u0101jis darbs, zi\u0146oja 46% aptauj\u0101to Latvij\u0101 un 37% ES kopum\u0101. Latvij\u0101 aptauj\u0101ti 1004 darbinieki.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">VDI direktors<strong> Ren\u0101rs L\u016bsis<\/strong> konferenc\u0113 nor\u0101d\u012bja, ka darbs var labv\u0113l\u012bgi ietekm\u0113t psihisko vesel\u012bbu, savuk\u0101rt neskaidri uzdevumi, \u012bsi termi\u0146i un sare\u017e\u0123\u012bjumi attiec\u012bb\u0101s ar kol\u0113\u0123iem var tai kait\u0113t. Darb\u0101 piedz\u012bvot\u0101s spriedzes ietekme var turpin\u0101ties ar\u012b p\u0113c darba laika.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u016bsis aicin\u0101ja darba dev\u0113jus psihosoci\u0101los riskus v\u0113rt\u0113t l\u012bdztekus p\u0101r\u0113jiem darba vides riskiem un vispirms nov\u0113rst to c\u0113lo\u0146us. Darbinieki b\u016btu j\u0101iesaista gan risku apzin\u0101\u0161an\u0101, gan risin\u0101jumu mekl\u0113\u0161an\u0101, savuk\u0101rt vad\u012bt\u0101jiem j\u0101nodro\u0161ina apm\u0101c\u012bbas, lai \u0161os riskus sp\u0113tu laikus paman\u012bt. Atbalsts darbiniekam var ietvert darba pien\u0101kumu, darba laika vai darba apst\u0101k\u013cu piel\u0101go\u0161anu, lai darbinieks atbilsto\u0161i iesp\u0113j\u0101m var\u0113tu turpin\u0101t darbu vai atgriezties taj\u0101.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Latvijas Br\u012bvo arodbiedr\u012bbu savien\u012bbas priek\u0161s\u0113d\u0113t\u0101ja vietniece <strong>Gita O\u0161k\u0101ja<\/strong> uzrun\u0101 sac\u012bja, ka gr\u016bt\u012bbas veikt darbu nereti var k\u013c\u016bdaini uztvert k\u0101 nev\u0113l\u0113\u0161anos str\u0101d\u0101t. Ja probl\u0113mu pamana nov\u0113loti, situ\u0101cija var beigties ar darba attiec\u012bbu p\u0101rtrauk\u0161anu. T\u0101p\u0113c, p\u0113c O\u0161k\u0101jas teikt\u0101, ir svar\u012bgi, lai darbinieks var\u0113tu atkl\u0101ti run\u0101t ar darba dev\u0113ju un darba dev\u0113js b\u016btu gatavs vi\u0146u uzklaus\u012bt un vajadz\u012bbas gad\u012bjum\u0101 main\u012bt darba apst\u0101k\u013cus.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">R\u012bgas Austrumu kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas izgl\u012bt\u012bbas un zin\u0101tnes direktors, asoci\u0113tais profesors un neirologs <strong>Ain\u0101rs Stepens<\/strong> nor\u0101d\u012bja, ka past\u0101v\u012bga sasniedzam\u012bba apgr\u016btina atsl\u0113g\u0161anos no darba, savuk\u0101rt pazi\u0146ojumi un bie\u017ea p\u0101rsl\u0113g\u0161an\u0101s starp uzdevumiem palielina slodzi uzman\u012bbai un darba atmi\u0146ai. P\u0113c vi\u0146a teikt\u0101, digit\u0101l\u0101 vide var veicin\u0101t psihosoci\u0101lo stresu, ta\u010du par t\u0101s lomu afekt\u012bvo un neirotisko trauc\u0113jumu pieaugum\u0101 pier\u0101d\u012bjumi pagaid\u0101m ir nepietiekami.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ar j\u0113dzienu &#8220;digit\u0101l\u0101 demence&#8221;, k\u0101 skaidroja Stepens, apz\u012bm\u0113 uzman\u012bbas, atmi\u0146as un m\u0101c\u012b\u0161an\u0101s sp\u0113ju pav\u0101jin\u0101\u0161anos, ko saista ar p\u0101rm\u0113r\u012bgu un pas\u012bvu viedier\u012b\u010du lieto\u0161anu. Vi\u0146\u0161 to raksturoja k\u0101 publicistisku apz\u012bm\u0113jumu potenci\u0101li atgriezenisk\u0101m gr\u016bt\u012bb\u0101m. Vi\u0146\u0161 ar\u012b min\u0113ja, ka j\u0113gpilna tehnolo\u0123iju lieto\u0161ana var pal\u012bdz\u0113t uztur\u0113t kognit\u012bv\u0101s sp\u0113jas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Stepens atsauc\u0101s uz medic\u012bnas \u017eurn\u0101l\u0101 &#8220;The Lancet&#8221; public\u0113taj\u0101m apl\u0113s\u0113m, ka l\u012bdz 45% demences gad\u012bjumu var\u0113tu nov\u0113rst vai aizkav\u0113t, mazinot 14 ietekm\u0113jamus riska faktorus dz\u012bves gait\u0101. Starp tiem ir dzirdes zudums, paaugstin\u0101ts zema bl\u012bvuma lipoprote\u012bnu holester\u012bna l\u012bmenis, paaugstin\u0101ts asinsspiediens, depresija, mazkust\u012bgums, sm\u0113\u0137\u0113\u0161ana un soci\u0101l\u0101 izol\u0101cija<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Konferenc\u0113 paredz\u0113ts ar\u012b atkl\u0101t EU-OSHA kampa\u0146u &#8220;Vesel\u012bbai nekait\u012bgas darbavietas 2026.-2028. gad\u0101&#8221;, kuras uzman\u012bbas centr\u0101 ir psihoemocion\u0101l\u0101 vesel\u012bba darb\u0101. Konferences nosl\u0113gum\u0101 apbalvos labas prakses konkursa &#8220;Zelta \u0137ivere 2026&#8221; laure\u0101tus.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Kampa\u0146as m\u0113r\u0137is ir veicin\u0101t psihosoci\u0101lo risku savlaic\u012bgu atpaz\u012b\u0161anu un nov\u0113r\u0161anu, k\u0101 ar\u012b pieredzes apmai\u0146u par praktiskiem risin\u0101jumiem. Ar\u012b konkursa &#8220;Zelta \u0137ivere 2026&#8221; \u0161\u0101 gada t\u0113ma ir psihosoci\u0101lo risku atpaz\u012b\u0161ana un nov\u0113rt\u0113\u0161ana. Taj\u0101 izce\u013c darba dev\u0113ju pieredzi un praktiskos risin\u0101jumus \u0161o risku mazin\u0101\u0161anai.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">VDI v\u0113r\u0161 uzman\u012bbu, ka <strong>psihosoci\u0101lie riski darbaviet\u0101 bie\u017ei paliek nepaman\u012bti. Pie tiem pieder p\u0101rm\u0113r\u012bga darba slodze, neskaidri darba pien\u0101kumi, nepietiekams vad\u012bbas atbalsts, savstarp\u0113ji konflikti, emocion\u0101la vardarb\u012bba un nelabv\u0113l\u012bgs psiholo\u0123iskais klimats kolekt\u012bv\u0101<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160o risku ietekme var uzkr\u0101ties, pasliktinot darbinieku vesel\u012bbu, darbsp\u0113jas un savstarp\u0113j\u0101s attiec\u012bbas. Ilgsto\u0161a risku iedarb\u012bba var veicin\u0101t izdeg\u0161anu, miega trauc\u0113jumus un trauksmi, savuk\u0101rt uz\u0146\u0113mumos var pieaugt darbinieku main\u012bba un darba kav\u0113jumu skaits, k\u0101 ar\u012b sarukt produktivit\u0101te, nor\u0101da VDI.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Inspekcija atg\u0101dina, ka darba dev\u0113ja pien\u0101kums nov\u0113rt\u0113t darba vides riskus un \u012bstenot prevent\u012bvus pas\u0101kumus attiecas ar\u012b uz psihosoci\u0101lajiem riskiem. To mazin\u0101\u0161anai darba dev\u0113ji var regul\u0101ri aptauj\u0101t darbiniekus, p\u0101rskat\u012bt darba slodzi un organiz\u0101ciju, apm\u0101c\u012bt vad\u012bt\u0101jus un darbiniekus, k\u0101 ar\u012b ieviest atbalsta pas\u0101kumus. VDI uzsver, ka darbinieku iesaiste pal\u012bdz laikus paman\u012bt probl\u0113mas, kuras vad\u012bbai ikdien\u0101 var palikt neredzamas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Avots: LETA<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Izteiktu laika tr\u016bkumu vai p\u0101rslodzi darb\u0101 izj\u016bt 39% Latvij\u0101 aptauj\u0101to darbinieku, savuk\u0101rt Eiropas Savien\u012bb\u0101 (ES) par to zi\u0146oju\u0161i 44% aptauj\u0101to, liecina Valsts darba inspekcijas (VDI) piektdienas konferenc\u0113 apl\u016bkot\u0101s Eiropas Darba [&hellip;]<\/p>\n","protected":false},"author":37,"featured_media":13491,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[76],"tags":[3309,545,3310,1517],"mic_flag":[63],"class_list":["post-23428","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunakie-raksti","tag-digitala-demence","tag-parslodze","tag-valsts-darba-inspekcija","tag-vdi","mic_flag-aktuali"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Izteiktu laika tr\u016bkumu vai p\u0101rslodzi darb\u0101 izj\u016bt 39% Latvij\u0101 aptauj\u0101to darbinieku, savuk\u0101rt Eiropas Savien\u012bb\u0101 (ES) par to zi\u0146oju\u0161i 44% aptauj\u0101to, liecina Valsts darba inspekcijas (VDI) piektdienas konferenc\u0113 apl\u016bkot\u0101s Eiropas Darba dro\u0161\u012bbas un vesel\u012bbas aizsardz\u012bbas a\u0123ent\u016bras (EU-OSHA) aptaujas &quot;OSH Pulse 2025&quot; dati. VDI sadarb\u012bb\u0101 ar EU-OSHA piektdien r\u012bko konferenci &quot;Redz\u0113t neredzamo: psihosoci\u0101lo risku atpaz\u012b\u0161ana un nov\u0113rt\u0113\u0161ana\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"olita@mic.lv\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Izteiktu laika tr\u016bkumu vai p\u0101rslodzi darb\u0101 izj\u016bt 39% Latvij\u0101 aptauj\u0101to darbinieku, savuk\u0101rt Eiropas Savien\u012bb\u0101 (ES) par to zi\u0146oju\u0161i 44% aptauj\u0101to, liecina Valsts darba inspekcijas (VDI) piektdienas konferenc\u0113 apl\u016bkot\u0101s Eiropas Darba dro\u0161\u012bbas un vesel\u012bbas aizsardz\u012bbas a\u0123ent\u016bras (EU-OSHA) aptaujas &quot;OSH Pulse 2025&quot; dati. VDI sadarb\u012bb\u0101 ar EU-OSHA piektdien r\u012bko konferenci &quot;Redz\u0113t neredzamo: psihosoci\u0101lo risku atpaz\u012b\u0161ana un nov\u0113rt\u0113\u0161ana\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-11-13T14:30:41+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-11-13T14:40:30+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Izteiktu laika tr\u016bkumu vai p\u0101rslodzi darb\u0101 izj\u016bt 39% Latvij\u0101 aptauj\u0101to darbinieku, savuk\u0101rt Eiropas Savien\u012bb\u0101 (ES) par to zi\u0146oju\u0161i 44% aptauj\u0101to, liecina Valsts darba inspekcijas (VDI) piektdienas konferenc\u0113 apl\u016bkot\u0101s Eiropas Darba dro\u0161\u012bbas un vesel\u012bbas aizsardz\u012bbas a\u0123ent\u016bras (EU-OSHA) aptaujas &quot;OSH Pulse 2025&quot; dati. VDI sadarb\u012bb\u0101 ar EU-OSHA piektdien r\u012bko konferenci &quot;Redz\u0113t neredzamo: psihosoci\u0101lo risku atpaz\u012b\u0161ana un nov\u0113rt\u0113\u0161ana\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"name\":\"Jaun\\u0101kie raksti\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"position\":2,\"name\":\"Jaun\\u0101kie raksti\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/#listItem\",\"name\":\"Aptauja: 39% darbinieku izj\\u016bt izteiktu laika tr\\u016bkumu vai p\\u0101rslodzi\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/#listItem\",\"position\":3,\"name\":\"Aptauja: 39% darbinieku izj\\u016bt izteiktu laika tr\\u016bkumu vai p\\u0101rslodzi\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"name\":\"Jaun\\u0101kie raksti\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/#newsarticle\",\"name\":\"Aptauja: 39% darbinieku izj\\u016bt izteiktu laika tr\\u016bkumu vai p\\u0101rslodzi - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"Aptauja: 39% darbinieku izj\\u016bt izteiktu laika tr\\u016bkumu vai p\\u0101rslodzi\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/olita\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/reto-slimibu-pacients-patient.png\",\"width\":1000,\"height\":667},\"datePublished\":\"2026-11-13T16:30:41+02:00\",\"dateModified\":\"2026-11-13T16:40:30+02:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/#webpage\"},\"articleSection\":\"Jaun\\u0101kie raksti, digit\\u0101l\\u0101 demence, p\\u0101rslodze, Valsts Darba inspekcija, VDI, Aktu\\u0101li\",\"dateline\":\"Published on November 13, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/olita\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/olita\\\/\",\"name\":\"olita@mic.lv\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a4e749f03194dabf8c7c2f4d535a473abc8e2ee2d36c914fde7dd2e7e1273ec?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"olita@mic.lv\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/\",\"name\":\"Aptauja: 39% darbinieku izj\\u016bt izteiktu laika tr\\u016bkumu vai p\\u0101rslodzi - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Izteiktu laika tr\\u016bkumu vai p\\u0101rslodzi darb\\u0101 izj\\u016bt 39% Latvij\\u0101 aptauj\\u0101to darbinieku, savuk\\u0101rt Eiropas Savien\\u012bb\\u0101 (ES) par to zi\\u0146oju\\u0161i 44% aptauj\\u0101to, liecina Valsts darba inspekcijas (VDI) piektdienas konferenc\\u0113 apl\\u016bkot\\u0101s Eiropas Darba dro\\u0161\\u012bbas un vesel\\u012bbas aizsardz\\u012bbas a\\u0123ent\\u016bras (EU-OSHA) aptaujas \\\"OSH Pulse 2025\\\" dati. VDI sadarb\\u012bb\\u0101 ar EU-OSHA piektdien r\\u012bko konferenci \\\"Redz\\u0113t neredzamo: psihosoci\\u0101lo risku atpaz\\u012b\\u0161ana un nov\\u0113rt\\u0113\\u0161ana\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/olita\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/olita\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/reto-slimibu-pacients-patient.png\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/#mainImage\",\"width\":1000,\"height\":667},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\\\/#mainImage\"},\"datePublished\":\"2026-11-13T16:30:41+02:00\",\"dateModified\":\"2026-11-13T16:40:30+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi - Medikamentu Inform\u0101cijas Centrs","description":"Izteiktu laika tr\u016bkumu vai p\u0101rslodzi darb\u0101 izj\u016bt 39% Latvij\u0101 aptauj\u0101to darbinieku, savuk\u0101rt Eiropas Savien\u012bb\u0101 (ES) par to zi\u0146oju\u0161i 44% aptauj\u0101to, liecina Valsts darba inspekcijas (VDI) piektdienas konferenc\u0113 apl\u016bkot\u0101s Eiropas Darba dro\u0161\u012bbas un vesel\u012bbas aizsardz\u012bbas a\u0123ent\u016bras (EU-OSHA) aptaujas \"OSH Pulse 2025\" dati. VDI sadarb\u012bb\u0101 ar EU-OSHA piektdien r\u012bko konferenci \"Redz\u0113t neredzamo: psihosoci\u0101lo risku atpaz\u012b\u0161ana un nov\u0113rt\u0113\u0161ana","canonical_url":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","name":"Jaun\u0101kie raksti"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","position":2,"name":"Jaun\u0101kie raksti","item":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/#listItem","name":"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/#listItem","position":3,"name":"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","name":"Jaun\u0101kie raksti"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/#newsarticle","name":"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi - Medikamentu Inform\u0101cijas Centrs","headline":"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/olita\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png","width":1000,"height":667},"datePublished":"2026-11-13T16:30:41+02:00","dateModified":"2026-11-13T16:40:30+02:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/#webpage"},"articleSection":"Jaun\u0101kie raksti, digit\u0101l\u0101 demence, p\u0101rslodze, Valsts Darba inspekcija, VDI, Aktu\u0101li","dateline":"Published on November 13, 2026."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/olita\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/olita\/","name":"olita@mic.lv","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/0a4e749f03194dabf8c7c2f4d535a473abc8e2ee2d36c914fde7dd2e7e1273ec?s=96&d=mm&r=g","width":96,"height":96,"caption":"olita@mic.lv"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/","name":"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi - Medikamentu Inform\u0101cijas Centrs","description":"Izteiktu laika tr\u016bkumu vai p\u0101rslodzi darb\u0101 izj\u016bt 39% Latvij\u0101 aptauj\u0101to darbinieku, savuk\u0101rt Eiropas Savien\u012bb\u0101 (ES) par to zi\u0146oju\u0161i 44% aptauj\u0101to, liecina Valsts darba inspekcijas (VDI) piektdienas konferenc\u0113 apl\u016bkot\u0101s Eiropas Darba dro\u0161\u012bbas un vesel\u012bbas aizsardz\u012bbas a\u0123ent\u016bras (EU-OSHA) aptaujas \"OSH Pulse 2025\" dati. VDI sadarb\u012bb\u0101 ar EU-OSHA piektdien r\u012bko konferenci \"Redz\u0113t neredzamo: psihosoci\u0101lo risku atpaz\u012b\u0161ana un nov\u0113rt\u0113\u0161ana","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/olita\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/olita\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png","@id":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/#mainImage","width":1000,"height":667},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/#mainImage"},"datePublished":"2026-11-13T16:30:41+02:00","dateModified":"2026-11-13T16:40:30+02:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi - Medikamentu Inform\u0101cijas Centrs","og:description":"Izteiktu laika tr\u016bkumu vai p\u0101rslodzi darb\u0101 izj\u016bt 39% Latvij\u0101 aptauj\u0101to darbinieku, savuk\u0101rt Eiropas Savien\u012bb\u0101 (ES) par to zi\u0146oju\u0161i 44% aptauj\u0101to, liecina Valsts darba inspekcijas (VDI) piektdienas konferenc\u0113 apl\u016bkot\u0101s Eiropas Darba dro\u0161\u012bbas un vesel\u012bbas aizsardz\u012bbas a\u0123ent\u016bras (EU-OSHA) aptaujas &quot;OSH Pulse 2025&quot; dati. VDI sadarb\u012bb\u0101 ar EU-OSHA piektdien r\u012bko konferenci &quot;Redz\u0113t neredzamo: psihosoci\u0101lo risku atpaz\u012b\u0161ana un nov\u0113rt\u0113\u0161ana","og:url":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png","og:image:width":1000,"og:image:height":667,"article:published_time":"2026-11-13T14:30:41+00:00","article:modified_time":"2026-11-13T14:40:30+00:00","twitter:card":"summary_large_image","twitter:title":"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Izteiktu laika tr\u016bkumu vai p\u0101rslodzi darb\u0101 izj\u016bt 39% Latvij\u0101 aptauj\u0101to darbinieku, savuk\u0101rt Eiropas Savien\u012bb\u0101 (ES) par to zi\u0146oju\u0161i 44% aptauj\u0101to, liecina Valsts darba inspekcijas (VDI) piektdienas konferenc\u0113 apl\u016bkot\u0101s Eiropas Darba dro\u0161\u012bbas un vesel\u012bbas aizsardz\u012bbas a\u0123ent\u016bras (EU-OSHA) aptaujas &quot;OSH Pulse 2025&quot; dati. VDI sadarb\u012bb\u0101 ar EU-OSHA piektdien r\u012bko konferenci &quot;Redz\u0113t neredzamo: psihosoci\u0101lo risku atpaz\u012b\u0161ana un nov\u0113rt\u0113\u0161ana","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png"},"aioseo_meta_data":{"post_id":"23428","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"NewsArticle","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-11-13 14:30:43","updated":"2026-11-13 15:46:28"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/\" title=\"Jaun\u0101kie raksti\">Jaun\u0101kie raksti<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tAptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Jaun\u0101kie raksti","link":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/"},{"label":"Aptauja: 39% darbinieku izj\u016bt izteiktu laika tr\u016bkumu vai p\u0101rslodzi","link":"https:\/\/farmacija-mic.lv\/en\/aptauja-39-darbinieku-izjut-izteiktu-laika-trukumu-vai-parslodzi\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/37"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=23428"}],"version-history":[{"count":1,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23428\/revisions"}],"predecessor-version":[{"id":23429,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23428\/revisions\/23429"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/13491"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=23428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=23428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=23428"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=23428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}